Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (NCT07729189) titled 'Prophylactic Use of Timolol Maleate to Prevent Intraocular Pressure Elevation After Nd:YAG Laser Posterior Capsulotomy' on July 22.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Prevention. Masking: Single (Participant).
Primary Sponsor: CMH Multan Institute of Medical Sciences
Condition:
Capsule Opacification
Ocular Hypertension
Intervention:
Drug: Timolol Maleate
Recruitment Status: Not recruiting
Phase: N/A
Date of First Enrollment: March 10, 2025
Target Sample Size: 210
Countries of Recruitment:
Pakistan
To know more, visi...